What's breaking now, across thousands of outlets.
Contineum Therapeutics and Johnson & Johnson’s oral M1 receptor inhibitor has missed its second mid-stage study in a year, this time in major depressive disorder. The drug, called PIPE-307 or JNJ-5120, failed to show statistically ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
[Vanguard] GOMBE -- The All Progressives Congress (APC), Gombe State chapter, has accused the Peoples Democratic Party (PDP) of politicising the diphtheria outbreak in the state, describing the…
Jorge Martin suffered another physical setback during the San Marino GP weekend, adding to the injuries that have plagued him since he joined Aprilia last year.
The outbreak is the second most lethal on record, behind only one in West Africa
The drug stabilized kidney function and reduced the risk of death and other complications in IgAN patients
WIRED tested samples of four types of peptides. The results show how lightly regulated the industry is, even as popularity surges.
There will also be art therapy sessions and stress management programmes at the centre.
